These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17636188)

  • 1. Singlet oxygen potentiates thrombolysis.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):259-78. PubMed ID: 17636188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Singlet oxygen enhances intrinsic thrombolysis: the intrinsic oxidative clot lysis assay (INOXCLA).
    Stief TW
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):369-83. PubMed ID: 17911188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro simulation of therapeutic thrombolysis with microtiter plate clot-lysis assay.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):21-32. PubMed ID: 16444431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro simulation of therapeutic plasmatic fibrinolysis.
    Stief TW; Bünder R; Richter A; Maisch B; Renz H; Fareed J
    Clin Appl Thromb Hemost; 2003 Jul; 9(3):211-20. PubMed ID: 14507109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the global fibrinolytic state.
    Stief TW; Fröhlich S; Renz H
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):479-87. PubMed ID: 17581324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
    Stief TW; Stief MH; Ehrenthal W; Darius H; Martin E
    Thromb Res; 1991 Dec; 64(5):597-610. PubMed ID: 1808764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonradical excited oxygen species induce selective thrombolysis in vivo.
    Stief TW
    Thromb Res; 1991 May; 62(3):147-63. PubMed ID: 1716380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V; Pannell R
    Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
    [No Abstract]   [Full Text] [Related]  

  • 11. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.
    Fry ET; Mack DL; Sobel BE
    Thromb Haemost; 1989 Nov; 62(3):909-16. PubMed ID: 2512679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Singlet oxygen (1O(2)) disrupts platelet aggregates.
    Stief TW; Feek U; Ramaswamy A; Kretschmer V; Renz H; Fareed J
    Thromb Res; 2001 Dec; 104(5):361-70. PubMed ID: 11738079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxidants on proteases of the fibrinolytic system: possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin.
    Stief TW; Martín E; Jimenez J; Digón J; Rodriguez JM
    Thromb Res; 1991 Feb; 61(3):191-200. PubMed ID: 1827545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin converts singlet oxygen (1O2)-oxidized fibrinogen into a soluble t-PA cofactor. A new method for preparing a stimulator for functional t-PA assays.
    Stief TW; Kretschmer V; Kosche B; Doss MO; Renz H
    Ann Hematol; 2001 Apr; 80(4):189-94. PubMed ID: 11401083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hemostasis by singlet-oxygen (1DeltaO2*).
    Stief TW
    Curr Vasc Pharmacol; 2004 Oct; 2(4):357-62. PubMed ID: 15320815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antithrombotic factor singlet oxygen/light (1O2/h nu).
    Stief TW; Fareed J
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):22-30. PubMed ID: 10726045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional determination of plasminogen activator in arginine-stabilized plasma.
    Stief TW; Richter A; Bünder R; Maisch B; Renz H
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):311-23. PubMed ID: 16015417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.